SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-08-001493
Filing Date
2008-08-25
Accepted
2008-08-25 17:00:27
Documents
1
Period of Report
2008-09-25
Effectiveness Date
2008-08-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT avant_def14a.htm DEF 14A 340572
  Complete submission text file 0001206774-08-001493.txt   342097
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 081037188
SIC: 2835 In Vitro & In Vivo Diagnostic Substances